Raising the bar: triple therapy for pulmonary arterial hypertension associated with congenital heart disease

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

(2022) Marc Humbert et al.   EUROPEAN HEART JOURNAL

The effects of parenteral prostacycline therapy as add-on treatment to oral compounds in Eisenmenger syndrome

(2019) Michele D'Alto et al.   EUROPEAN RESPIRATORY JOURNAL

Subcutaneous treprostinil in congenital heart disease-related pulmonary arterial hypertension

(2018) Nika Skoro-Sajer et al.   HEART

Predictors of Death in Contemporary Adult Patients With Eisenmenger SyndromeClinical Perspective

(2016) Aleksander Kempny et al.   CIRCULATION

Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial

(2010) K. Iversen et al.   EUROPEAN HEART JOURNAL

Bosentan–sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology

(2010) Michele D'Alto et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY